Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05298332 Org: User:
Start: 03/29/22 End: 08/22/22 Due: 08/22/23

A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05137600 Org: User:
Start: 10/28/21 End: 01/23/22 Due: 01/23/23

A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT05238844 Org: User:
Start: 04/11/22 End: 05/25/22 Due: 05/25/23

A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT04248426 Org: User:
Start: 02/05/20 End: 05/18/21 Due: 05/18/22

A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection

Phase: N/A Priority: Normal
NCT ID: NCT04847440 Org: User:
Start: 03/30/21 End: 09/01/22 Due: 09/01/23

A Drug-Drug Interaction Study Between ATI-2173 and Tenofovir Disoproxil Fumarate in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05137548 Org: User:
Start: 10/27/21 End: 12/23/21 Due: 12/23/22